Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In a randomized, double-blind trial, no difference was seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo.
More news for Thursday, Sept. 22
Sep 21, 2016
Senate Finance Committee passes Retirement Enhancement and Savings Act … Fed votes to leave interest rates unchanged … Loneliness is a heritable trait, study finds … Can nicotine protect...
Students design bathing chair for residents with dementia
By
Lois A. Bowers
Jun 14, 2016
Montana State University students have designed a chair to improve the bathing experience for senior living residents who have dementia — and their caregivers.
Former CNA pleads guilty to planning sexual assaults of residents
By
Lois A. Bowers
Jun 07, 2016
A former certified nursing assistant at an Illinois assisted living and memory care community faces up to 15 years in prison after pleading guilty to three counts of solicitation to commit aggravated criminal...
Hippocampal atrophy linked to cognitive decline in older adults
Nov 17, 2023
The association was independent of Aβ and tau and accounted for 10% of the variance in cognitive decline.
More news for Wednesday, May 25
By
Kimberly Bonvissuto
May 25, 2022
Healthcare sector among most breached due to weak passwords … Partnership expands assisted living community’s medical services, home health, affordable housing … First responders undergo dementia...
‘Movie Moments’ event aims to increase inclusivity, decrease stigma around dementia
By
Sean Caulfield
Nov 20, 2017
An event featuring classic movies addresses how inclusion applies to individuals living with Alzheimer’s disease and other forms of dementia.
Senior living community penalized after resident with dementia elopes, dies
By
Lois A. Bowers
Mar 30, 2017
A North Carolina senior living community has been told not to accept new residents after a resident with dementia wandered away from the community and later was found dead. The community also has been...
Pharmaceutical company to pay $96 million to settle claims of promoting unapproved use of drug for dementia...
By
Lois A. Bowers
Sep 27, 2019
Pharmaceutical company Avanir has agreed to pay $96 million to resolve federal False Claims Act allegations that it paid kickbacks and marketed the drug Nuedexta in long-term care communities for the off-label...
More news for Friday, Aug. 12
Aug 11, 2016
Dementia care added to Medicare Advantage insurance model … Last suspect in assisted living/memory care CNA’s sexual assault plot arrested